ACRS

ACRS Stock-Based Compensation

$11.66MTTM · USD

Period ending:

ACRS FY Stock-Based CompUSD
ACRS FY Stock-Based Comp2013-12-31: $0.002014-12-31: $27.00K2015-12-31: $891.00K2016-12-31: $6.10M2017-12-31: $14.43M2018-12-31: $20.06M2019-12-31: $0.002020-12-31: $11.21M2021-12-31: $14.06M2022-12-31: $15.04M2023-12-31: $20.54M2024-12-31: $10.86M2025-12-31: $12.38M$20.54M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ACRS stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Aclaris Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
12,384,000
10,856,000
20,542,000
15,039,000
14,060,000
11,207,000
0
20,055,000
14,430,000
6,104,000
891,000
27,000
0

Compare stock-based compensation

All ACRS financial metrics · ACRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.